Cite
Heald AH, Martin S, Fachim H, et al. Genetically defined favourable adiposity is not associated with a clinically meaningful difference in clinical course in people with type 2 diabetes but does associate with a favourable metabolic profile. Diabet Med. 2021;38(9):e14531doi: 10.1111/dme.14531.
Heald, A. H., Martin, S., Fachim, H., Green, H. D., Young, K. G., Malipatil, N., Siddals, K., Cortes, G., Tyrrell, J., Wood, A. R., Beaumont, R. N., Frayling, T. M., Donn, R., Narayanan, R. P., Ollier, W., Gibson, M., & Yaghootkar, H. (2021). Genetically defined favourable adiposity is not associated with a clinically meaningful difference in clinical course in people with type 2 diabetes but does associate with a favourable metabolic profile. Diabetic medicine : a journal of the British Diabetic Association, 38(9), e14531. https://doi.org/10.1111/dme.14531
Heald, Adrian H, et al. "Genetically defined favourable adiposity is not associated with a clinically meaningful difference in clinical course in people with type 2 diabetes but does associate with a favourable metabolic profile." Diabetic medicine : a journal of the British Diabetic Association vol. 38,9 (2021): e14531. doi: https://doi.org/10.1111/dme.14531
Heald AH, Martin S, Fachim H, Green HD, Young KG, Malipatil N, Siddals K, Cortes G, Tyrrell J, Wood AR, Beaumont RN, Frayling TM, Donn R, Narayanan RP, Ollier W, Gibson M, Yaghootkar H. Genetically defined favourable adiposity is not associated with a clinically meaningful difference in clinical course in people with type 2 diabetes but does associate with a favourable metabolic profile. Diabet Med. 2021 Sep;38(9):e14531. doi: 10.1111/dme.14531. Epub 2021 Feb 11. PMID: 33501652.
Copy
Download .nbib
